Leaderboard

En | De
No articles selected!     View Cart  
You are here: Gastroenterology » Pankreas » Neoplasms 23. August 2026
Search
medline.ch
Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Gastrointestinal
Esophagus
Pankreas
Neoplasms
Pancreatitis
Others
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 3063  Previews Next
   
   Articles 1 - 20 / 61250  
   
Exploration of the mechanism of gut microbiota-mediated immune modulation in the pathogenesis of pancreatic cancer: A Mendelian randomization study.
Medicine (Baltimore)
Cai M, Cheng H, Jia Y, Qiu T, Liu Z, Xu J, Li H, Zhang Z, Wang J.
PMID: 42629734 [PubMed - indexed for MEDLINE]


A retrospective comparative study of CT and MRI findings of different types of pancreatic serous cystic neoplasms: Correlation with histopathology.
Medicine (Baltimore)
Li G, Lei A, Zhao J, Wang P, Ji G, Han X, Li P, Li B.
PMID: 42629710 [PubMed - indexed for MEDLINE]


Development and preliminary evaluation of a Neuman Systems Model-based protocol for postoperative delirium prevention in patients undergoing pancreatic cancer surgery.
Medicine (Baltimore)
Wang S, Yu L, Xu W.
PMID: 42629707 [PubMed - indexed for MEDLINE]


Clinical Translation of Patient-Derived Organoids: Perspectives for Personalized Therapy in Cancer.
Int J Cancer
Yue H, Carchidi D, Schmucker P, Seiler R, Kiss B, Macedo-Silva C, Kruithof-de Julio M.
PMID: 42629644 [PubMed - as supplied by publisher]


Seamless Phase I-II Cancer Clinical Trials Using Kernel-Based Covariate Similarity.
Pharm Stat
Makino K, Makigusa N, Kojima M.
PMID: 42629327 [PubMed - indexed for MEDLINE]


Emerging Issue - Fatty Pancreas in Pancreatic Cystic Neoplasms: Results of a Matched Case-Control Study.
Dig Dis Sci
Vl, Bilous D, Sandru V, Buz, Prodan R, Bugeac C, Chiriac O, Tianu E, Ciocîrlan M.
PMID: 42627603 [PubMed - as supplied by publisher]


Exploring facilitators and barriers to the implementation of prehabilitation for individuals with pancreatic cancer: a survey of healthcare professionals.
Support Care Cancer
Wrench E, McGladrigan E, Lauder RM, Dunne D, Shelton C, Lambert J, Machin LL, Subar DA, Bampouras TM, Gaffney CJ.
PMID: 42627527 [PubMed - indexed for MEDLINE]


Solid Pseudopapillary Neoplasm of the Pancreas: Diagnostic Concordance and Clinicopathologic Correlation of Fine-Needle Aspiration and Long-Term Outcomes.
Cureus
Dejban P, Wang EZ, Ahsan BU, Yuan L.
PMID: 42626592 [PubMed]


Risk prediction models for malnutrition in patients with cancer: a systematic review.
Front Nutr
Jiang K, Pan J, Zhang Y.
PMID: 42626291 [PubMed]


Distinct prognostic impact of diabetes subtypes, metformin use, and glycemic control in pancreatic cancer: a systematic review and meta-analysis of cohort studies.
Front Oncol
Li G, Peng Z, Wang Y, Zhu Z, Huang S, Yu J, Huang H.
PMID: 42625611 [PubMed]


Prognostic utility of the Charlson comorbidity index in pancreatic cancer: a systematic review and meta‑analysis.
World J Surg Oncol
Yang J, Wang S, Bai X, Song H.
PMID: 42625189 [PubMed - indexed for MEDLINE]


Human endogenous retroviruses as immune-related prognostic biomarkers in pancreatic cancer.
BMC Cancer
Toma PI, Gales LN, Ghiringhelli F, Trandafir A, Budea RI, Ilie SM.
PMID: 42625160 [PubMed - indexed for MEDLINE]


Pan-cancer profiles of mesothelin (MSLN) unveil diagnostic potential and therapeutic targetability of pancreatic adenocarcinoma.
PLoS One
Sheikh MR, Mistry B, Shafin RH, Apu A, Sara TH, Tasnim J, Dutta D, Nandy A, Rahman A.
PMID: 42623414 [PubMed - indexed for MEDLINE]


Incidental cystic pancreatic neuroendocrine neoplasm and differential diagnosis.
Radiol Case Rep
Martin D, Taylor ER, Abdallah E, Haider M, Ferguson K, Jeong D, Feuerlein S, Costello JR.
PMID: 42621430 [PubMed]


Meta-analysis of the relationship between preoperative systemic immune inflammation index and prognosis of patients with biliary tract cancer.
Biomark Med
Liang J, Wang Z, Lv D, Tuo H.
PMID: 42619611 [PubMed - as supplied by publisher]


Zinc-based nanoplatforms for cancer immunotherapy achieved through the cyclic GMP-AMP synthase-stimulator of interferon genes pathway: Bridging tumor metabolism and immune activation.
Acta Biomater
Wang Y, Wang Y, Zhang C, Li D, Fu X, Wang T, Zhang L, Wang Y.
PMID: 42617782 [PubMed - as supplied by publisher]


ESMO Clinical Practice Guideline Express Update on daraxonrasib in the treatment of metastatic pancreatic cancer.
Ann Oncol
Conroy T, Ducreux M, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org.
PMID: 42617733 [PubMed - as supplied by publisher]


What matters most early in the cancer trajectory: patient concerns and priorities in pancreatic and lung cancer (BetterEveryDay trial).
Eur J Oncol Nurs
Mikkelsen MK, Rolin L, Theile S, Markman MJN, Hald C, Chen IM.
PMID: 42617508 [PubMed - as supplied by publisher]


Biofabrication and artificial intelligence strategies for investigating solid- and fluid-pressure mechanobiology in pancreatic ductal adenocarcinoma.
Cancer Metastasis Rev
Ding Y, Zhao P, Jin Y, Li Y, Wang Z, Lu Y, Zhang Y, Chen H, Zhang W, Luan X, Tang M.
PMID: 42616191 [PubMed - indexed for MEDLINE]


Chemotherapy for Unresectable Pancreatic Cancer Complicated by Disseminated Intravascular Coagulation: A Retrospective Cohort Study.
Pancreas
Nagata K, Ando T, Kawanaka H, Sakamoto J, Ogino B, Entani T, Motoo I, Ueda Y, Hayashi N, Kajiura S, Tajiri K, Yasuda I.
PMID: 42616029 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 61250    Page 1 of 3063  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1